TABLE 2.
GO: Biological process | |||||||
---|---|---|---|---|---|---|---|
Term | GO # | Overlap | p-value | Adj. p | Z-score | Combined Score | Genes |
Synaptic transmission, GABAergic | 51,932 | 3/12 | 7.83E–05 | 0.05354 | −2.45 | 23.13 | GABRA2;GABRE;GABRG3 |
GABA signaling pathway | 7214 | 3/20 | 3.89E–04 | 0.132938 | −2.06 | 16.21 | GABRA2;GABRE;GABRG3 |
L-amino acid transport | 15,807 | 3/26 | 8.59E–04 | 0.195793 | −2.22 | 15.68 | PRAF2;SLC3A2;SLC38A5 |
Regulation of postsynaptic membrane potential | 60,078 | 3/34 | 1.89E–03 | 0.257775 | −1.51 | 9.49 | GABRA2;GABRE;GABRG3 |
Chemical synaptic transmission, postsynaptic | 99,565 | 3/34 | 1.89E–03 | 0.257775 | −1.45 | 9.09 | GABRA2;GABRE;GABRG3 |
GO: Cellular component | |||||||
Term | GO # | Overlap | p-value | Adj. p | Z-score | Combined Score | Genes |
GABA-A receptor complex | 1,902,711 | 3/20 | 3.89E–04 | 0.023457 | −2.19 | 17.20 | GABRA2;GABRE;GABRG3 |
dendrite membrane | 32,590 | 3/21 | 4.51E–04 | 0.023457 | −2.78 | 21.38 | GABRA2;GABRE;GABRG3 |
germ plasm | 60,293 | 2/14 | 4.49E–03 | 0.123421 | −2.36 | 12.75 | TDRD1;SNRPG |
Cytoskeleton | 5856 | 10/521 | 4.75E–03 | 0.123421 | −1.58 | 8.45 | BCAS3;ACTR1A;EDA;MYOT; MVP;SHROOM2;MYOZ3; NPM3;S100A9;MDN1 |
P granule | 43,186 | 2/17 | 6.61E–03 | 0.137495 | −2.35 | 11.81 | TDRD1;SNRPG |
GO: Molecular function | |||||||
Term | GO # | Overlap | p-value | Adj. p | Z-score | Combined Score | Genes |
Benzodiazepine receptor activity | 8503 | 3/11 | 5.90E–05 | 0.009565 | −2.81 | 27.34 | GABRA2;GABRE;GABRG3 |
GABA-gated chloride ion channel activity | 22,851 | 3/13 | 1.01E–04 | 0.009565 | −2.49 | 22.93 | GABRA2;GABRE;GABRG3 |
Inhibitory extracellular ligand-gated ion channel activity | 5237 | 3/16 | 1.95E–04 | 0.012288 | −2.39 | 20.38 | GABRA2;GABRE;GABRG3 |
Ligand-gated anion channel activity | 99,095 | 3/19 | 3.32E–04 | 0.014028 | −2.16 | 17.29 | GABRA2;GABRE;GABRG3 |
GABA-A receptor activity | 4890 | 3/20 | 3.89E–04 | 0.014028 | −2.09 | 16.42 | GABRA2;GABRE;GABRG3 |